Institution

Fred and Pamela Buffett Cancer Center

Omaha, United StatesWebsite

Also known as: Buffett Cancer Center · Buffett Cancer Center Omaha · Buffett Cancer Center at the University of Nebraska Medical Center · Fred and Pamela Buffett Cancer Center at the University of Nebraska Medical Center · UNMC Buffett Cancer Center · UNMC Fred and Pamela Buffett Cancer

1running trial
1closed trial
2,088publications (OpenAlex)

Running trials

Active, not recruiting
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
NCT06388564· Phase 2· Incyte Corporation· Source

Closed trials

Completed
Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT03778931· Phase 3· Stemline Therapeutics, Inc.· Source

Registry name variants (2)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Fred and Pamela Buffett Cancer Center
Omaha, Nebraska 68198
1 trial
- NCT06388564A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
The Fred & Pamela Buffett Cancer Center
Omaha, Nebraska 68105
1 trial
- NCT03778931Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer

Conditions

Diseases this institution publishes on or runs trials for.

Pancreatic cancer27 works · 0 trials

Institution data: ROR 03n63wv08 (CC0-1.0)Updated 14 Nov 2026

Report an error